Jeffrey Calhoun
Low Vision Rehabilitation · Williamsville, NYNPI 1700878006
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 48 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 23.1% — the pattern of someone who eats at a lot of different presentations.
Across 48 payments — averaging $56.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb Americas Inc.$622
- Bausch & Lomb, A Division Of Bausch Health US, LLC$594
- Coopervision Inc.$354
- Biotissue Holdings Inc.$269
- Alcon$192
- Tarsus Pharmaceuticals, Inc.$125
- plus $537 from 9 others
What the payments were for
- Food & beverage$2,67499%
- Gifts$191%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb Americas Inc. | 11 | $622 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 7 | $594 |
| Coopervision Inc. | 9 | $354 |
| Biotissue Holdings Inc. | 3 | $269 |
| Alcon | 5 | $192 |
| Tarsus Pharmaceuticals, Inc. | 1 | $125 |
| Harrow Eye, LLC | 1 | $121 |
| Amgen | 2 | $115 |
| LKC Technologies, Inc. | 1 | $96 |
| Sight Sciences, Inc. | 2 | $81 |
| Topcon Healthcare, Inc. | 1 | $57 |
| Maculogix, Inc. | 1 | $21 |
| Carl Zeiss Meditec AG | 1 | $19 |
| ABB Con-cise Optical Group LLC | 2 | $14 |
| Optovue, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,693 in reported general payments places this provider in the 75th percentile of 20 low vision rehabilitation providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XiidraLifitegrast | 41 | $32,736 |
| LumiganBimatoprost | 20 | $7,633 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 20 | $4,502 |
| Brimonidine Tartrate | 37 | $4,077 |
| Brinzolamide | 11 | $3,106 |
| Latanoprost | 169 | $2,457 |
| Travoprost | 18 | $1,534 |
| Timolol Maleate | 23 | $826 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 37 | $537 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Bausch & Lomb Americas Inc.Xiidra | $622 | $32,73641 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 20 low vision rehabilitation providers in New York.
Other low vision rehabilitation in Williamsville
- Todd PunimMonroe$4K
- Kristin ProtosowRonkonkoma$4K
- Tracy SheedyRed Hook$3K
- Howard FishmanNew Hyde Park$3K
- John RundquistAmherst$2K
- Charles HollanderNew York$2K
- Emily ChuForest Hills$814
- Robert ChunNew York$448
- Carolyn IhrigFredonia$368
- Shandor ZelengerNew York$263
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.